Johnson & Johnson (JNJ)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
163.81-0.94 (-0.57%)
At close: 4:00PM EDT
163.63 -0.18 (-0.11%)
After hours: 05:30PM EDT
After hours: 05:30PM EDT
| Previous Close | 164.75 |
| Open | 163.48 |
| Bid | 163.82 x 1000 |
| Ask | 164.40 x 900 |
| Day's Range | 162.17 - 165.17 |
| 52 Week Range | 133.65 - 179.92 |
| Volume | 7,001,716 |
| Avg. Volume | 5,937,990 |
| Market Cap | 431.377B |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | 28.94 |
| EPS (TTM) | 5.66 |
| Earnings Date | Oct. 19, 2021 |
| Forward Dividend & Yield | 4.24 (2.56%) |
| Ex-Dividend Date | Aug. 23, 2021 |
| 1y Target Est | 187.17 |
- Editor's PickYahoo Finance Video
Doctor reacts to U.S. travel ban changes
Baylor College of Medicine Assistant Professor Dr. Sara Andrabi joins Yahoo Finance to discuss the requirement of vaccinations for foreign travelers and other trends amid the COVID-19 pandemic.
- Editor's PickYahoo Finance Video
Early tests show Pfizer’s Covid-19 vaccine for kids ages 5 to 11 is ‘very safe’: Epidemiologist
Suzanne Judd, Ph.D., Epidemiologist at the University of Alabama at Birmingham School of Public Health, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
- Editor's PickYahoo Finance Video
3 reasons why FDA advisors rejected Pfizer’s booster for the general public
Meg Fitzgerald, “Ascending Davos” Author and Columbia University Healthcare Policy Professor, joins Yahoo Finance Live to discuss the future of vaccines, the FDA rejecting Pfizer's booster shot for the general public and the importance of getting young children vaccinated as soon as possible.
© 2021 Verizon Media. All rights reserved.
